Sujal Shah, Chief Executive Officer at CymaBay Therapeutics, Inc. (CBAY), sold 129,722 shares at $14.20 ($1.8M) on 2023-10-09, disclosed to the SEC on 2023-10-10.
Scheduled sale ($1.8M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.20 | 64,861 | $921K | 50.0% |
| 2 | $14.20 | 64,861 | $921K | 50.0% |
| Total | $14.20 avg | 129,722 | $1.8M | 100% |
| Filing → |
| CBAY | BUY | 2022-06-07 | $200K | — | Filing → |
| CBAY | BUY | 2019-10-15 | $22K | — | Filing → |
| CBAY | BUY | 2019-09-24 | $28K | — | Filing → |